Human papillomavirus (HPV) causes more than 90% of cervical and anal cancers, more
than 70% of oropharyngeal cancers, and a substantial proportion of vaginal, vulvar, and …

Adolescence is characterised by low mortality. Young people entering adolescence have
survived the ravages of infant and child mortality and most do not yet face the chronic health …

Currently, screening programmes for cervical cancer usually rely on cytology as the first-line
screen. 1 Women who are found to be cytologically abnormal are triaged by carcinogenic …

For more than a decade, public health practitioners and researchers have been asking how
uptake of a safe and effective anticancer vaccine can be improved. In this issue of The …

World Report mandate comprehensive sex education for both boys and girls in the schools”,
says Pamela DiCarlo, who is disinclined to inoculate her 10-year-old daughter.“That would …

An investigational 9-valent vaccine against human papillomavirus (9vHPV) had an efficacy
of nearly 97% against cervical, vulvar, and vaginal disease associated with HPV types 31 …

Clinical trials of a vaccine directed against HPV oncogenes for the treatment of cervical
carcinoma are in progress. 1 The underlying rationale is to stimulate specific cytotoxic T …

HPV-based cervical-cancer screening in China. - Abstract - Europe PMC Sign in | Create an
account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us …

On Feb 5, 2018, Public Health England (PHE) announced that from April 2018, men who
have sex with men (MSM), aged 45 years and younger in England, will be offered free …

We welcome Anne Philpott and colleagues' proposal that barriers against sexually
transmitted diseases should be designed to promote sexual pleasure (Dec 2, p 2028). 1 We …